The prevalence of diabetic nephropathy in conservative hemodialysis patients of Mazandaran and Golestan, 1998

Objective: Progressive course of diabetic nephropathy (DM), which is an important cause of death among diabetics, ultimately leads to permanent hemodialysis. DN is the most common cause of end-stage renal failure in most countries. Methods: Identification and treatment of DM predisposing factors in...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: B Heidari
Formato: article
Lenguaje:EN
FA
Publicado: Babol University of Medical Sciences 1999
Materias:
R
Acceso en línea:https://doaj.org/article/11b472f5fbb643e88e7beecb2eaaa3b2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:11b472f5fbb643e88e7beecb2eaaa3b2
record_format dspace
spelling oai:doaj.org-article:11b472f5fbb643e88e7beecb2eaaa3b22021-11-10T09:24:31ZThe prevalence of diabetic nephropathy in conservative hemodialysis patients of Mazandaran and Golestan, 19981561-41072251-7170https://doaj.org/article/11b472f5fbb643e88e7beecb2eaaa3b21999-10-01T00:00:00Zhttp://jbums.org/article-1-2938-en.htmlhttps://doaj.org/toc/1561-4107https://doaj.org/toc/2251-7170Objective: Progressive course of diabetic nephropathy (DM), which is an important cause of death among diabetics, ultimately leads to permanent hemodialysis. DN is the most common cause of end-stage renal failure in most countries. Methods: Identification and treatment of DM predisposing factors in hemodialysis patient was done in seven provincial Mazandaran and Golestan dialysis centers of Mazandaran and Golestan, all patients who underwent permanent hemodialysis in 1998 were studied. Etiologic studies in renal failure have been conducted using the patient’s last hospital admission history. The information about diabetes provided by interview, medical examination and completion of questionnaires. Diabetes typing was done using the national diabetes data group criteria. Findings: The results show that 32 of 353 hemodialysis patients of Mazandaran and Golestan (9%) have DM. 26 of the diabetics were type 2 and the others were type 1. The average age of patients and of starting hemodialysis in type 2 diabetes were 57.5±9.4, 54±10.4 years and 38.5±9.5, 35±1 years and in type 1. Conclusion: In comparison with foreign countries the prevalence of DM in Mazandaran and Golestan is lower. The reasons for the difference may be, geographic differences in diabetes prevalence and the predisposing factors of DM, early death of patients with DM before starting hemodialysis or different criteria for choosing and introducing patients for hemodialysis.B HeidariBabol University of Medical Sciencesarticlehemodialysis patientsdiabetic nephropathyprevalenceMedicineRMedicine (General)R5-920ENFAMajallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Bābul, Vol 1, Iss 4, Pp 26-31 (1999)
institution DOAJ
collection DOAJ
language EN
FA
topic hemodialysis patients
diabetic nephropathy
prevalence
Medicine
R
Medicine (General)
R5-920
spellingShingle hemodialysis patients
diabetic nephropathy
prevalence
Medicine
R
Medicine (General)
R5-920
B Heidari
The prevalence of diabetic nephropathy in conservative hemodialysis patients of Mazandaran and Golestan, 1998
description Objective: Progressive course of diabetic nephropathy (DM), which is an important cause of death among diabetics, ultimately leads to permanent hemodialysis. DN is the most common cause of end-stage renal failure in most countries. Methods: Identification and treatment of DM predisposing factors in hemodialysis patient was done in seven provincial Mazandaran and Golestan dialysis centers of Mazandaran and Golestan, all patients who underwent permanent hemodialysis in 1998 were studied. Etiologic studies in renal failure have been conducted using the patient’s last hospital admission history. The information about diabetes provided by interview, medical examination and completion of questionnaires. Diabetes typing was done using the national diabetes data group criteria. Findings: The results show that 32 of 353 hemodialysis patients of Mazandaran and Golestan (9%) have DM. 26 of the diabetics were type 2 and the others were type 1. The average age of patients and of starting hemodialysis in type 2 diabetes were 57.5±9.4, 54±10.4 years and 38.5±9.5, 35±1 years and in type 1. Conclusion: In comparison with foreign countries the prevalence of DM in Mazandaran and Golestan is lower. The reasons for the difference may be, geographic differences in diabetes prevalence and the predisposing factors of DM, early death of patients with DM before starting hemodialysis or different criteria for choosing and introducing patients for hemodialysis.
format article
author B Heidari
author_facet B Heidari
author_sort B Heidari
title The prevalence of diabetic nephropathy in conservative hemodialysis patients of Mazandaran and Golestan, 1998
title_short The prevalence of diabetic nephropathy in conservative hemodialysis patients of Mazandaran and Golestan, 1998
title_full The prevalence of diabetic nephropathy in conservative hemodialysis patients of Mazandaran and Golestan, 1998
title_fullStr The prevalence of diabetic nephropathy in conservative hemodialysis patients of Mazandaran and Golestan, 1998
title_full_unstemmed The prevalence of diabetic nephropathy in conservative hemodialysis patients of Mazandaran and Golestan, 1998
title_sort prevalence of diabetic nephropathy in conservative hemodialysis patients of mazandaran and golestan, 1998
publisher Babol University of Medical Sciences
publishDate 1999
url https://doaj.org/article/11b472f5fbb643e88e7beecb2eaaa3b2
work_keys_str_mv AT bheidari theprevalenceofdiabeticnephropathyinconservativehemodialysispatientsofmazandaranandgolestan1998
AT bheidari prevalenceofdiabeticnephropathyinconservativehemodialysispatientsofmazandaranandgolestan1998
_version_ 1718440076784959488